UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Secondary mutations of BRCA1/2 and drug resistance

Cancer science, 2011-04, Vol.102 (4), p.663-669

2011

Volltextzugriff (PDF)

Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers

International journal of hematology, 2017-09, Vol.106 (3), p.335-344

2017

Volltextzugriff (PDF)

Molecular pathogenesis of Fanconi anemia: recent progress

Blood, 2006-06, Vol.107 (11), p.4223-4233

2006

Volltextzugriff (PDF)

Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas

Journal of clinical oncology, 2011-08, Vol.29 (22), p.3008-3015

2011

Volltextzugriff (PDF)

Proteasome function is required for DNA damage response and fanconi anemia pathway activation

Cancer research (Chicago, Ill.), 2007-08, Vol.67 (15), p.7395-7405

2007

Volltextzugriff (PDF)

Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer

Journal of clinical oncology, 2010-08, Vol.28 (22), p.3555-3561

2010

Volltextzugriff (PDF)

Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L

American journal of human genetics, 2016-06, Vol.98 (6), p.1146-1158

2016

Volltextzugriff (PDF)

Secondary mutations as a mechanism of cisplatin resistance in BRCA2 -mutated cancers

Nature, 2008-02, Vol.451 (7182), p.1116-1120

2008

Volltextzugriff (PDF)

MiR-96 Downregulates REV1 and RAD51 to Promote Cellular Sensitivity to Cisplatin and PARP Inhibition

Cancer research (Chicago, Ill.), 2012-08, Vol.72 (16), p.4037-4046

2012

Volltextzugriff (PDF)

REV1-POL ζ Inhibition and Cancer Therapy

Molecular cell, 2019-08, Vol.75 (3), p.419-420

Taniguchi, Toshiyasu

2019

Volltextzugriff (PDF)

FANCI Regulates Recruitment of the FA Core Complex at Sites of DNA Damage Independently of FANCD2

PLoS genetics, 2015-10, Vol.11 (10), p.e1005563-e1005563

2015

Volltextzugriff (PDF)

ATR couples FANCD2 monoubiquitination to the DNA-damage response

Genes & development, 2004-08, Vol.18 (16), p.1958-1963

2004

Volltextzugriff (PDF)

MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression

Molecular cancer research, 2011-08, Vol.9 (8), p.1100-1111

2011

Volltextzugriff (PDF)

Ubiquitination-Linked Phosphorylation of the FANCI S/TQ Cluster Contributes to Activation of the Fanconi Anemia I/D2 Complex

Cell reports (Cambridge), 2017-06, Vol.19 (12), p.2432-2440

2017

Volltextzugriff (PDF)

RFWD3 and translesion DNA polymerases contribute to PCNA modification-dependent DNA damage tolerance

Life science alliance, 2022-07, Vol.5 (12), p.e202201584

2022

Volltextzugriff (PDF)

The fanconi anemia (FA) pathway confers glioma resistance to DNA alkylating agents

Journal of molecular medicine (Berlin, Germany), 2007-05, Vol.85 (5), p.497-509

2007

Volltextzugriff (PDF)

The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability

Human molecular genetics, 2005-03, Vol.14 (5), p.693-701

2005

Volltextzugriff (PDF)

Human Fanconi Anemia Monoubiquitination Pathway Promotes Homologous DNA Repair

Proceedings of the National Academy of Sciences - PNAS, 2005-01, Vol.102 (4), p.1110-1115

2005

Volltextzugriff (PDF)

Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway

Molecular cell, 2001-02, Vol.7 (2), p.249-262

2001

Volltextzugriff (PDF)

Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin

Molecular cancer, 2012-04, Vol.11 (1), p.26-26, Article 26

2012

Volltextzugriff (PDF)

Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors

Nature medicine, 2003-05, Vol.9 (5), p.568-574

2003

Volltextzugriff (PDF)

DGCR8 Mediates Repair of UV-Induced DNA Damage Independently of RNA Processing

Cell reports (Cambridge), 2017-04, Vol.19 (1), p.162-174

2017

Volltextzugriff (PDF)

Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway

Molecular cancer therapeutics, 2006-04, Vol.5 (4), p.952-961

2006

Volltextzugriff (PDF)

Phosphorylation of FANCD2 on Two Novel Sites Is Required for Mitomycin C Resistance

Molecular and Cellular Biology, 2006-09, Vol.26 (18), p.7005-7015

2006

Volltextzugriff (PDF)

Abstract IA06: The Fanconi anemia-BRCA pathway and cancer

Molecular cancer research, 2017-04, Vol.15 (4_Supplement), p.IA06-IA06

Taniguchi, Toshiyasu

2017

Volltextzugriff (PDF)

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(103)

Publikationsform

Artikel
(112)
Berichte
(1)

Sprache

Englisch
(108)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(77)
Life Sciences & Biomedicine
(70)
Humans
(62)
Biological And Medical Sciences
(29)
Female
(27)
Oncology
(25)
Medical Sciences
(23)
Dna Repair
(22)
Fanconi Anemia - Genetics
(19)
Cell Biology
(18)
Dna Damage
(18)
Animals
(16)
Male
(15)
Biochemistry & Molecular Biology
(14)
Fanconi Anemia Complementation Group D2 Protein
(13)
Hematology
(13)
Hela Cells
(12)
Nuclear Proteins - Metabolism
(12)
Dna
(11)
Fanconi Anemia
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Secondary mutations of BRCA1/2 and drug resistance

Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers

Molecular pathogenesis of Fanconi anemia: recent progress

Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas

Proteasome function is required for DNA damage response and fanconi anemia pathway activation

Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer

Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L

Secondary mutations as a mechanism of cisplatin resistance in BRCA2 -mutated cancers

MiR-96 Downregulates REV1 and RAD51 to Promote Cellular Sensitivity to Cisplatin and PARP Inhibition

REV1-POL ζ Inhibition and Cancer Therapy

FANCI Regulates Recruitment of the FA Core Complex at Sites of DNA Damage Independently of FANCD2

ATR couples FANCD2 monoubiquitination to the DNA-damage response

MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression

Ubiquitination-Linked Phosphorylation of the FANCI S/TQ Cluster Contributes to Activation of the Fanconi Anemia I/D2 Complex

RFWD3 and translesion DNA polymerases contribute to PCNA modification-dependent DNA damage tolerance

The fanconi anemia (FA) pathway confers glioma resistance to DNA alkylating agents

The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability

Human Fanconi Anemia Monoubiquitination Pathway Promotes Homologous DNA Repair

Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway

Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin

Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors

DGCR8 Mediates Repair of UV-Induced DNA Damage Independently of RNA Processing

Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway

Phosphorylation of FANCD2 on Two Novel Sites Is Required for Mitomycin C Resistance

Abstract IA06: The Fanconi anemia-BRCA pathway and cancer

Suchergebnisse filtern